GlaxoSmithKline and Pfizer Inc. Says Future IPO Possible For ViiV Healthcare

November 10, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

NEW YORK Nov 9 (Reuters) - An HIV company set up a year ago by GlaxoSmithKline Plc (GSK.L) and Pfizer Inc (PFE.N) could be spun off and floated in an initial public offering once its drug pipeline has matured a little further.

Twitter
LinkedIn
Facebook
Email
Print

IPO

Pfizer GlaxoSmithKline